{
    "pmcid": "11725859",
    "qa_pairs": {
        "How does AbMAP enhance prediction accuracy for antibody properties?": [
            "By using contrastive augmentation and multitask learning.",
            "By increasing the dataset size of antibody sequences.",
            "By incorporating evolutionary conservation principles.",
            "By focusing solely on the framework regions of antibodies."
        ],
        "What advantage does AbMAP have over existing methods for antibody design?": [
            "It offers a scalable and efficient approach by focusing on CDRs and leveraging foundational PLMs.",
            "It provides a faster method for sequencing antibody genes.",
            "It increases the thermal stability of antibodies.",
            "It reduces the cost of antibody production by 50%."
        ],
        "What is the primary focus of the AbMAP framework introduced in the paper?": [
            "Improving the modeling of antibody hypervariable regions.",
            "Enhancing the speed of protein sequence alignment.",
            "Developing new vaccines for SARS-CoV-2.",
            "Increasing the diversity of antibody libraries."
        ],
        "What specific challenge do foundational PLMs face when modeling antibodies?": [
            "They struggle with the hypervariability of complementarity-determining regions (CDRs).",
            "They cannot predict the tertiary structure of proteins.",
            "They are unable to process large protein sequences efficiently.",
            "They lack the ability to identify antigen binding sites."
        ],
        "What was the result of applying AbMAP to SARS-CoV-2 nanobody design?": [
            "An 82% hit rate and up to a 22-fold increase in binding affinity.",
            "A 50% reduction in computational time for antibody modeling.",
            "A 10% increase in the diversity of antibody candidates.",
            "A 30% improvement in the stability of designed antibodies."
        ]
    }
}